BILL ANALYSIS

HR4206

BULLISH

CONNECT for Health Act of 2025

HR4206 (CONNECT for Health Act of 2025) has been assessed with a bullish outlook for investors. This legislation directly affects $AMWL, CVS Health ($CVS), $TDOC and UnitedHealth Group ($UNH). The primary sectors impacted are Healthcare and Technology. View the full bill text on Congress.gov.

bullish

Market Sentiment

4

Affected Stocks

2

Sectors Impacted

Key Takeaways for Investors

1

HR4206 has 234 cosponsors and an identical Senate companion—strong bipartisan momentum for permanent Medicare telehealth expansion.

2

Bill is early-stage (referred to committee); no guaranteed passage, but high cosponsor count and pandemic legacy increase odds.

3

Pure-play telehealth tickers $TDOC and $AMWL are direct structural beneficiaries; payor-provider systems $UNH and $CVS gain from lower-cost care substitution.

4

No direct appropriations—impact is through Medicare reimbursement rule changes that expand the addressable market for virtual care.

5

Current stock prices do not reflect this legislative catalyst; $TDOC and $AMWL trade near 52-week lows, suggesting market skepticism about near-term passage.

How HR4206 Affects the Market

The CONNECT for Health Act represents a structural catalyst for the telehealth sector, even though passage is uncertain at this early stage. $TDOC at $5.38 and $AMWL at $5.86 are pricing in no legislative benefit—both trade near the bottom quartile of their 52-week ranges. If the bill advances to markup or receives a favorable CBO score, these stocks are positioned for significant upside. Behind the scenes, $UNH ($363.93, up 34.49% in 30 days) and $CVS ($82.86, up 15.37% over 30 days) are already pricing in broader value-based care momentum, but HR4206 passage would further support their margins by expanding virtual care options for their Medicare Advantage populations. The pure-play names offer higher beta and more direct leverage to passage, while the diversified payors offer lower risk with structural margin improvement over time.

Bill Details

MetricValue
Bill NumberHR4206
Market Sentimentbullish
Event Date
Affected SectorsHealthcare, Technology
Affected Stocks$AMWL, CVS Health ($CVS), $TDOC, UnitedHealth Group ($UNH)
SourceView on Congress.gov →

Summary

The CONNECT for Health Act of 2025 (HR4206) is a broad, bipartisan bill to permanently expand Medicare telehealth coverage by removing geographic and originating site restrictions, eliminating the six-month in-person visit requirement for telemental health, and adding eligible practitioners. The bill is early-stage (referred to committee) with 234 cosponsors and an identical Senate companion (S1261), indicating strong legislative momentum. Pure-play telehealth platforms $TDOC and $AMWL face structural tailwinds from increased addressable demand, while integrated payor-provider systems $UNH and $CVS gain from lower-cost care channels and improved medical cost ratios. The bill authorizes no direct spending but increases the addressable market for virtual care services by expanding Medicare reimbursement eligibility.

Full AI Market Analysis

1) What happened and its current status: Rep. Mike Thompson (D-CA) introduced HR4206 on June 26, 2025—the CONNECT for Health Act of 2025, a bill to permanently expand Medicare telehealth coverage. The bill was referred to the House Committees on Energy and Commerce and Ways and Means. It is an early-stage authorization bill with no appropriations attached. The identical Senate companion bill S1261 was introduced by Sen. Schatz (D-HI). The bill has 234 cosponsors, a very high number reflecting broad bipartisan support for telehealth expansion following the pandemic-era flexibilities that expired in 2025. The bill is still in committee; no hearings or markups have occurred yet. 2) The money trail: HR4206 is an authorization bill that amends Title XVIII of the Social Security Act to expand Medicare telehealth coverage—it does NOT authorize any specific dollar amount of spending. The financial impact is indirect: by expanding the population eligible for telehealth services (removing geographic restrictions, allowing home as originating site, adding FQHCs, RHCs, and Native American health facilities, and repealing the six-month in-person requirement for telemental health), the bill increases the total addressable market (TAM) for telehealth services within Medicare. The Congressional Budget Office (CBO) would score this bill; historically, telehealth expansion bills have been scored as net savers because virtual care reduces expensive ER visits and inpatient admissions. The mechanism is regulatory relief—CMS must update its telehealth reimbursement rules to cover more services, sites, and practitioners. Companies that provide telehealth platforms or operate virtual care networks will see increased utilization and reimbursement revenue as Medicare beneficiaries gain broader access. 3) Structural winners and losers: Winners are telehealth platform providers ($TDOC, $AMWL) that directly benefit from increased Medicare utilization; integrated payor-provider systems with Medicare Advantage exposure ($UNH, $CVS) that can reduce medical costs by substituting virtual visits for in-person care, particularly for chronic disease management and mental health; and technology/device vendors that supply remote patient monitoring (RPM) and virtual care hardware. Losers include traditional in-person healthcare facilities that may see volume shift to virtual care, particularly urgent care centers and rural clinics that previously had geographic monopolies on Medicare services. No negative tickers are listed because the net effect on the named companies is positive. 4) Real market data analysis: Based on the provided Yahoo Finance data, $TDOC closed at $5.38 on April 30, 2026, down 6.43% over 7 days and down 1.28% over 30 days—trading near the low end of its 52-week range ($4.4–$9.77). $AMWL closed at $5.86, down 0.34% over 7 days but up 11.41% over 30 days. Both stocks react to policy catalysts; the lack of near-term price movement reflects that HR4206 is still in early committee stage. $UNH closed at $363.93, up 2.54% over 7 days and 34.49% over 30 days—strong performance driven by earnings and forward guidance. $CVS closed at $82.86, up 6.31% over 7 days and 15.37% over 30 days, approaching the top of its 52-week range. The 30-day strength in UNH and CVS reflects broader healthcare sector momentum rather than specific telehealth legislation pricing in. 5) Timeline: HR4206 is at the beginning of a long legislative journey. The bill must pass through both House committees (Energy and Commerce, Ways and Means), receive a floor vote in the House, pass the Senate (identical companion S1261 is in Senate Finance), and be signed by the President. Given 234 cosponsors and the Senate companion bill, passage probability within the 119th Congress (which runs through January 2027) is moderate-to-high. The earliest potential enactment is mid-2026. Investors should watch for committee markups and CBO scoring as signals of legislative velocity.

Stocks Affected by HR4206

Sectors Impacted by HR4206

Related Healthcare Legislation

Understand the Terms

Track Bills Like HR4206 Daily

Get AI-analyzed alerts when Congress moves markets.

Get Started →